Picture of Herantis Pharma Oyj logo

HRTIS — Herantis Pharma Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Herantis Pharma: Antti Vuolanto Appointed CEO

July 8 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * ANTTI VUOLANTO APPOINTED AS CEO OF HERANTIS AS OF 22 JULY
2022
    * FRANS WUITE WILL CONTINUE AS INTERIM CEO OF HERANTIS
PHARMA PLC
UNTIL 21 JULY 2022 AND AS MEMBER OF BOARD ALSO THEREAFTER

Source text for Eikon:  ID:nWkr2rwlfR 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Herantis Pharma Oyj

See all news